Department of Nephrology, Chao-Yang Hospital, Capital Medical University
Beijing, 100020, China
NCT Number: NCT01455974
Unfavorably high sodium intakes remain prevalent around the world. A negative sodium gradient in hemodialysis treatment results in absolute sodium removal via diffusive transport of sodium from the blood to the dialysate, and it may be a potentially useful tool to improve sodium loading due to excess dietary sodium intake.
The purpose of this study is to determine whether a in small negative sodium gradient could improve blood pressure level, arterial stiffness and left ventricular hypertrophy in hypertensive hemodialysis patients, who had been achieving and maintaining their dry weight assessed by bioimpedance spectroscopy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Beijing, 100020, China
A number of studies have shown that lowering dialysate sodium concentration could improve blood pressure (BP) control, and the lower BPs are considered to be a result of an improvement in volume status via increasing sodium removal. However, sodium, apart from volume, may have an independent effect on BP regulation. It is speculated that a reduction in exchangeable sodium, even without a change in body water content, may improve BP control. Unfortunately, as of yet, no clinical studies have actually provided the evidence in this field.
In general population, dietary salt loading produces significant increase in aortic pulse wave velocity, which is reversed by lowering sodium intake. To the investigators knowledge, the effect of sodium on arterial stiffness has not been investigated in hemodialysis patients.
A regression of left ventricular hypertrophy (LVH) has been achieved through strict dietary sodium restriction in hemodialysis patients. Lack of effect on LVH was observed in low sodium dialysis which may be due to the shorter time interval.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After 1-month period of dialysis with standard dialysate sodium concentration 138mmol/L, patients were followed up over a 1-year period with dialysate sodium set at 136mmol/L, without changes in instructions to patients about dietary sodium.
Time frame: Baseline, 4 months, and 12 months
The change is calculated as the 4 months minus baseline, and the 12 months minus baseline
Time frame: Baseline, 4 months, and 12 months
The change is calculated as the 4 months minus baseline, and the 12 months minus baseline
Capital Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03816462
Body Weight, Cardiomegaly
Baltimore, Maryland, United States
View Trial DetailsNCT03629912
Accidental Fall, Activities of Daily Living
Dixon, Kentucky, United States
View Trial DetailsNCT03666351
Aortic Regurgitation, Aortic Stenosis
Seoul, South Korea
View Trial DetailsNCT00985322
Cardiomegaly, Cardiovascular Diseases
Ponte San Pietro, Bergamo, Italy
View Trial Details